Furthermore, recent studies have found that the expression of SSTR2 in ovarian cancer tissue is quite high and SSTA has the capacity to inhibit and reverse paclitaxel resistance from multiple pathways [18–24]. The gene discussed is SSTR2; the disease is ovarian carcinoma.